NASDAQ:HVII · NASDAQ Global Select
-$0.01 today
Vol 0.00M · Avg 0.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Company filings are the primary source for understanding what changed inside Hennessy Capital Investment Corp. VII before the market fully reacts. Review recent HVII disclosures alongside price history and peer context to identify new risks, accounting changes, strategic updates, capital allocation decisions, and operating details that may affect the intrinsic value case.
Price History
Dividend-adjusted closing price
Change
+3.04%
Period High
$10.90
Period Low
$10.13
Latest
$10.47
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Drugs Made In America Acquisition Corp. Ordinary Shares
NASDAQ:DMAA
$359.09M
Bold Eagle Acquisition Corp.
NASDAQ:BEAG
$335.10M
Andretti Acquisition Corp. II
NASDAQ:POLE
$318.41M
Artius II Acquisition Inc. Class A Ordinary Shares
NASDAQ:AACB
$291.14M
Soulpower Acquisition Corp.
NYSE:SOUL
$265.69M
Oaktree Acquisition Corp. II
NASDAQ:OACC
$264.02M
Plum Acquisition Corp. IV
NASDAQ:PLMK
$258.67M
FACT II Acquisition Corp
NASDAQ:FACT
$258.54M
Armada Acquisition Corp. III
NASDAQ:AACI
$255.22M
Roman DBDR Acquisition Corp. II
NASDAQ:DRDB
$242.65M
What is the latest HVII filing?
The latest filing shown is 425 dated Jun 17, 2026.
How many recent filings does HVII have?
Intrinsic Alpha currently shows 20 recent filings for HVII.
Explore More
Continue the stock analysis
Jump to another research area for this company.